These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. In vitro model for lytic replication, latency, and transformation of an oncogenic alphaherpesvirus. Schermuly J; Greco A; Härtle S; Osterrieder N; Kaufer BB; Kaspers B Proc Natl Acad Sci U S A; 2015 Jun; 112(23):7279-84. PubMed ID: 26039998 [TBL] [Abstract][Full Text] [Related]
9. Isolation and development of a reticuloendotheliosis virus-transformed lymphoblastoid cell line from chicken spleen cells. Keller LH; Rufner R; Sevoian M Infect Immun; 1979 Aug; 25(2):694-701. PubMed ID: 226481 [TBL] [Abstract][Full Text] [Related]
10. Retroviral transformation in vitro of chicken T cells expressing either alpha/beta or gamma/delta T cell receptors by reticuloendotheliosis virus strain T. Marmor MD; Benatar T; Ratcliffe MJ J Exp Med; 1993 Mar; 177(3):647-56. PubMed ID: 8382253 [TBL] [Abstract][Full Text] [Related]
11. Further characterization of Marek's disease virus-infected lymphocytes. I. In vivo infection. Calnek BW; Schat KA; Ross LJ; Shek WR; Chen CL Int J Cancer; 1984 Mar; 33(3):389-98. PubMed ID: 6321364 [TBL] [Abstract][Full Text] [Related]
12. Suppression mediated in vitro by Marek's disease virus-transformed T-lymphoblastoid cell lines: effect on lymphoproliferation. Quere P Vet Immunol Immunopathol; 1992 Apr; 32(1-2):149-64. PubMed ID: 1318599 [TBL] [Abstract][Full Text] [Related]
13. Further characterization of Marek's disease virus-infected lymphocytes. II. In vitro infection. Calnek BW; Schat KA; Ross LJ; Chen CL Int J Cancer; 1984 Mar; 33(3):399-406. PubMed ID: 6321365 [TBL] [Abstract][Full Text] [Related]